- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05189886
Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty
In this study, the investigators evaluate whether routine double inflation of the valve could have a lasting impact. The investigators hypothesize that a routine second reinflation of the balloon, or "double tap", will improve flow across the valve when compared to a single inflation. The investigators hypothesize that "double tap" (1) will decrease mean gradient between first and second inflation during the procedure, (2) will decrease mean gradient on immediate post procedure and 30 day postprocedure echocardiograms when compared to mean gradient gradient after single inflation. Less obstruction indicated by lower mean gradient early after deployment may translate to improved 5 and 10 year outcomes. Furthermore, the investigators hypothesize that this small change in technique will have no effect on procedure time or complications and the change will not result in any increase in perioperative vascular complications, or new permanent pacemaker insertion.
The primary objective of this study is to determine if double valve inflation during a TAVR procedure improves valve area and mean gradients as measured by echocardiogram immediately following the procedure and at 30 days follow up.
연구 개요
연구 유형
등록 (예상)
연락처 및 위치
연구 연락처
- 이름: Erin Ross
- 전화번호: 8059488278
- 이메일: eross1@cmhshealth.org
연구 장소
-
-
California
-
Ventura, California, 미국, 93003
- 모병
- Community Memorial Hospital
-
연락하다:
- Erin Ross
- 전화번호: 805-948-8278
- 이메일: eross1@cmhshealth.org
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Male or female ≥18 years of age
- Diagnosis of severe native valve aortic stenosis
- Meets the standard of care indications to undergo TAVR procedure (aortic valve area <1.0 cm2 or mean pressure gradient >40 mmHg or peak velocity >4.0 m/s or aortic valve area index <0.6).
- Provided informed consent.
Exclusion Criteria:
- History of prior aortic valve replacement
- Pre-existing moderate to severe aortic regurgitation
- Lacking pre-procedure echocardiogram
- Patients planning to undergo multiple valve replacements simultaneously
- Intraoperative arrhythmia
- Intraoperative hemodynamic instability
- Intraoperative complication during initial inflation (such as: aortic dissection, coronary artery occlusion, coronary artery dissection)
- At the discretion of the principal investigator, any reason that the potential subject may be unfit for participation, such as frailty.
공부 계획
연구는 어떻게 설계됩니까?
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
---|---|
Prospective
The prospective phase will enroll patients planning to undergo TAVR, at the discretion of Drs.
Wan and Fatemi, and if they meet all of the inclusion criteria and none of the exclusion criteria.
All patients who provide consent will undergo the TAVR procedure where the valve will be double inflated.
Echocardiogram results and procedure details will be collected as data.
At the patient's 30-day follow-up clinic visit, as per standard of care, they will be re-evaluated with an echocardiogram.
Details from that follow-up visit and the echocardiogram results will be collected as data.
Prospective enrollment will begin upon IRB approval and we plan to continue enrollment until December 31, 2023, or once 200 participants are reached, whichever comes first.
|
The prospective phase will enroll patients planning to undergo TAVR, at the discretion of Drs.
Wan and Fatemi, and if they meet all of the inclusion criteria and none of the exclusion criteria.
All patients who provide consent will undergo the TAVR procedure where the valve will be double inflated.
Echocardiogram results and procedure details will be collected as data.
At the patient's 30-day follow-up clinic visit, as per standard of care, they will be re-evaluated with an echocardiogram.
Details from that follow-up visit and the echocardiogram results will be collected as data.
Prospective enrollment will begin upon IRB approval and we plan to continue enrollment until December 31, 2023, or once 200 participants are reached, whichever comes first.
|
Retrospective
The retrospective phase will collect data from previous TAVR procedures completed between February 2019 and October 1, 2021.
Data from up to 200 patient charts will be collected using the Society of Thoracic Surgeons/American College of Cardiology that is maintained by the CMH Cardiology Department.
The population will be de-identified as the purpose is to obtain descriptive information from the medical records to utilize for propensity match scoring.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Valve area
기간: Immediately following the procedure
|
Valve area as measured by echocardiogram
|
Immediately following the procedure
|
Valve area
기간: At 30 days follow up
|
Valve area as measured by echocardiogram
|
At 30 days follow up
|
Mean gradient
기간: Immediately following the procedure
|
Mean gradient as measured by echocardiogram
|
Immediately following the procedure
|
Mean gradient
기간: At 30 days follow up
|
Mean gradient as measured by echocardiogram
|
At 30 days follow up
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Jennifer Wan, MD, Community Memorial HealthCenter
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2021-HSR013
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Double Balloon Valvuloplasty in TAVR에 대한 임상 시험
-
Medstar Health Research Institute아직 모집하지 않음의지 실패 | 인공 밸브 오작동 | 경피적 심장 판막(THV) 장애가 있는 증상이 있는 환자